PsyBio Therapeutics Corp.
PSYBF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 775.90K | -811.50K | -941.60K | -921.90K | -1.44M |
| Total Depreciation and Amortization | 0.00 | 38.00K | 38.00K | 38.00K | 38.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -927.10K | 223.40K | 6.70K | 85.80K | 213.70K |
| Change in Net Operating Assets | -210.50K | 194.60K | 730.90K | 90.20K | -118.80K |
| Cash from Operations | -361.70K | -355.50K | -166.00K | -707.90K | -1.30M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 600.00 | -- | 0.00 | 856.70K | 1.38M |
| Cash from Investing | 600.00 | -- | 0.00 | 856.70K | 1.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -13.70K | -27.40K | -41.10K |
| Issuance of Common Stock | 244.50K | 294.00K | 156.40K | -- | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -76.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 314.20K | -3.20K | -- | -- | -7.00K |
| Cash from Financing | 558.70K | 290.80K | 142.70K | -27.40K | -124.30K |
| Foreign Exchange rate Adjustments | 700.00 | -700.00 | -100.00 | 500.00 | 200.00 |
| Miscellaneous Cash Flow Adjustments | -254.90K | -- | -- | -- | -- |
| Net Change in Cash | -56.60K | -65.30K | -23.40K | 122.00K | -49.80K |